Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.

Research output: Contribution to journalArticle

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)4695-4704
JournalJournal of Clinical Oncology
Volume23
Issue number21
Publication statusPublished - 2005
Publication categoryResearch
Peer-reviewedYes